このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

BioGaia マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Theresa Agnew

最高経営責任者

SEK 6.8m

報酬総額

CEO給与比率	19.4%
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	3.2yrs
取締役会の平均在任期間	3.2yrs

経営陣の近況

Recent updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28

CEO報酬分析

BioGaia の収益と比較して、Theresa Agnew の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	SEK 371m
Dec 31 2023	SEK 7m	SEK 1m	SEK 365m

報酬と市場: Theresaの総報酬 ($USD 646.87K ) は、 Swedish市場 ($USD 757.05K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Theresaの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Theresa Agnew (58 yo)

less than a year

在職期間

SEK 6,750,250

報酬

Ms. Theresa P. Agnew serves as President of BioGaia AB (publ) since September 2023 and serves as its Chief Executive Officer since 25 September 2023. She is a global business leader with consumer healthcar...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Peter Rothschild	Founder & Chairman	6.3yrs	SEK 1.33m	データなし
Theresa Agnew	CEO & President	less than a year	SEK 6.75m	データなし
Alexander Kotsinas	Executive VP & CFO	4.7yrs	SEK 3.07m	0.0030% SEK 373.1k
Ludvig Milesson	Chief Operating Officer	1.3yrs	データなし	0.0012% SEK 155.8k
Gianfranco Grompone	Chief Scientific Officer and VP of Research & Development	4.5yrs	データなし	データなし
Caroline Mofors	Chief Legal Officer	1.5yrs	データなし	データなし
Linda Hagglund	Vice President of Marketing	3.2yrs	データなし	0.00019% SEK 23.9k
Angelika Kjelldorff	Chief HR Officer	5.5yrs	データなし	0.00050% SEK 62.8k
Sebastian Heimfors	VP & Chief Commercial Officer	2.3yrs	データなし	データなし
Jonathan Gromark	Sustainability Manager	no data	データなし	データなし
Keitaro Nomura	MD & President of BioGaia Japan Inc.	no data	データなし	データなし

3.2yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: BIOG Bの経営陣は経験豊富であると考えられます ( 3.1年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Peter Rothschild	Founder & Chairman	6.3yrs	SEK 1.33m	データなし
David E. Dangoor	Independent Deputy Board Chairman	21.5yrs	SEK 590.00k	1.73% SEK 217.7m
Vesa Koskinen	Director	1.2yrs	SEK 275.00k	データなし
Barbro Friden	Director	1.2yrs	SEK 275.00k	0.00050% SEK 62.8k
Anthon Jahreskog	Independent Director	9.2yrs	SEK 405.00k	0.0040% SEK 502.5k
Vanessa Rothschild	Director	4.2yrs	SEK 275.00k	0.00016% SEK 20.1k
Benedicte Flambard	Director	2.2yrs	SEK 275.00k	データなし
Outi Armstrong	Director	1.2yrs	SEK 275.00k	データなし

3.2yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: BIOG Bの取締役会は経験豊富であると考えられます ( 3.1年の平均在任期間)。

BioGaia マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Less than half of directors are independent

Independent Director recently bought kr51k worth of stock

Vice President of RA & Legal recently bought kr103k worth of stock

Recent updates

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Third quarter 2021 earnings released

Price target increased to kr533

Second quarter 2021 earnings released: EPS kr2.71 (vs kr4.56 in 2Q 2020)

Consensus forecasts updated

BioGaia AB (publ) (OM:BIOG B) acquired remaining 8% stake in MetaboGen AB for SEK 11.4 million.

Vice President of RA & Legal recently bought kr103k worth of stock

First quarter 2021 earnings released

Biogaia AB (Publ) Approves Dividend

Upcoming dividend of kr3.41 per share

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

マネジメント基準チェック /34